期刊文献+

消化道肿瘤腹腔化疗的研究进展 被引量:3

Progress in Peritoneal Chemotherapy of Digestive Tract Malignant Tumors
下载PDF
导出
摘要 术后早期腹腔化疗(IPC)对消化道恶性肿瘤术后腹膜种植和肝转移的防治具有重意义,腹腔化疗作为区域性治疗手段,有其药代动力学优势,近年来研究证实,腹腔化疗联合腹膜切除术治疗消化道恶性肿瘤腹膜转移可提高疗效,腹腔化疗的优势亦能充分发挥。 Objective Early intraperitoneal chemotherapy postoperatively play a important role inprevention and treatment of digestive tract malignant tumors. As a method of regional therapy, theintraperitoneal chemotherapy has an advantage of the pharmacokinerics. Recent studies confirmed that theintraperitoneal chemotherapy combined with resection of peritoneal membrane may improve the treatmentoutcome of peritoneal metastasis of digestive tract malignant tumors. And the advantage of intraperi-toneal chemotherapy will be brought into full play.
作者 何耀武 黄岩
出处 《国际医药卫生导报》 2004年第18期221-223,共3页 International Medicine and Health Guidance News
关键词 消化道恶性肿瘤 腹腔化疗 Digestive tract malignant tumors Intraperitoneal chemotherapy
  • 相关文献

参考文献19

  • 1[1]Yoo CH, Noh Sh, Shin DW, et al. Recurrence following curative resection for gastric carcinoma. Br J Surg,2000, 87(2): 236~242
  • 2[2]Yonemura Y, Bandou E, Kinoshita K, et al. Effective therapy for peritoneal dissemination in gastric cancer.Surg Oncol Clin N Am, 2330, 12(3): 635~648
  • 3[3]0zols RF, Young RC. Semin Oncol, 1991, 18(3): 222~232
  • 4[4]Noh Sh , Yoo CH, Chung HC, et al. Early post operative intraperitoneal chemotherapy with mitomycin C, 5-fluorouracil and cisplatin for advanced gastric cancer.Oncology, 2001, 60(1): 24~30
  • 5[5]Esquivel J, Vidal-Jove J, Steves MA, et al. Surgery,1993, 113:631~636
  • 6[6]Rossi CR, Mocellin S, Pilati P, et al. Pharmacokinetics of intraperitoneal cisplatin and doxorubicin. Surg Oncol Clin N Am, 2003, 12(3): 781~794
  • 7[7]Pestieau SR, Belliveau JF, Griffin H, et al. Pharmacokinetics of intraperitoneal Oxaliplatin:Experimental Studies. J Surgical Oncology, 2001, 76(2): 106~114
  • 8[8]Elias D, Bonnay M, Puizillou JM, et al. Heated intraoperative intraperitonealoxalipltin after complete resection of peritoneal carcinomatosis: pharmacokinerics and tissue distribution. Ann Oncol, 2002, 13(2): 267~272
  • 9[9]Fushida S, Furui N,Kinami S, et al. Pharmacologic study of intraperitonealpaclitaxel in gastric cancer patients with peritoneal dissemination. Gan To Kagaku Ryoho, 2002, 29(12): 2164~2167
  • 10[10]Fushida S, Nao F, Kinami S, et al. Phamacologic study of intraperitoneal docetaxel in gastric cancer patients with peritoneal dissemination. Gan To Kagaku Ryohl, 2002, 29(10): 1759~1763

同被引文献27

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部